Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning

被引:125
作者
Lai, Wen-Sung
Xu, Bin
Westphal, Koen G. C.
Paterlini, Marta
Olivier, Berend
Pavlidis, Paul
Karayiorgou, Maria
Gogos, Joseph A.
机构
[1] Rockefeller Univ, Human Neurogenet Lab, New York, NY 10021 USA
[2] Univ Utrecht, Dept Pharmacol, NL-3584 CA Utrecht, Netherlands
[3] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA
[4] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada
[5] Univ British Columbia, Bioinformat Ctr, Vancouver, BC V6T 1Z4, Canada
[6] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
mouse model; psychiatric disease; susceptibility gene;
D O I
10.1073/pnas.0604994103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There is accumulating evidence that AKT signaling plays a role in the pathogenesis of schizophrenia. We asked whether Akt1 deficiency in mice results in structural and functional abnormalities in prefrontal cortex (PFC). Exploratory transcriptional profiling revealed concerted alterations in the expression of PFC genes controlling synaptic function, neuronal development, myelination, and actin polymerization, and follow-up ultrastructural analysis identified consistent changes in the dendritic architecture of pyramidal neurons. Behavioral analysis indicated that Akt1-mutant mice have normal acquisition of a PFC-clependent cognitive task but abnormal working memory retention under neurochemical challenge of three distinct neurotransmitter systems. Thus, Akt1 deficiency creates a context permissive for gene-gene and gene-environment interactions that modulate PFC functioning and contribute to the disease risk associated with this locus, the severity of the clinical syndrome, or both.
引用
收藏
页码:16906 / 16911
页数:6
相关论文
共 50 条
[1]   Modeling madness in mice: One piece at a time [J].
Arguello, P. Alexander ;
Gogos, Joseph A. .
NEURON, 2006, 52 (01) :179-196
[2]   Adrenergic targets for the treatment of cognitive deficits in schizophrenia [J].
Arnsten, AFT .
PSYCHOPHARMACOLOGY, 2004, 174 (01) :25-31
[3]   Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions [J].
Arnsten, AFT ;
Li, BM .
BIOLOGICAL PSYCHIATRY, 2005, 57 (11) :1377-1384
[4]   Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia [J].
Barch, DM ;
Carter, CS ;
Braver, TS ;
Sabb, FW ;
MacDonald, A ;
Noll, DC ;
Cohen, JD .
ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (03) :280-288
[5]   Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade [J].
Beaulieu, JM ;
Sotnikova, TD ;
Yao, WD ;
Kockeritz, L ;
Woodgett, JR ;
Gainetdinov, RR ;
Caron, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :5099-5104
[6]   An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior [J].
Beaulieu, JM ;
Sotnikova, TD ;
Marion, S ;
Lefkowitz, RJ ;
Gainetdinov, RR ;
Caron, MG .
CELL, 2005, 122 (02) :261-273
[7]   Acetylcholine: A neurotransmitter for learning and memory? [J].
Blokland, A .
BRAIN RESEARCH REVIEWS, 1995, 21 (03) :285-300
[8]   Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia [J].
Bunney, WE ;
Bunney, BG .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :138-146
[9]   Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia [J].
Castner, SA ;
Goldman-Rakic, PS ;
Williams, GV .
PSYCHOPHARMACOLOGY, 2004, 174 (01) :111-125
[10]   Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons [J].
Chalecka-Franaszek, E ;
Chuang, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8745-8750